ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) is a
neuropathological disorder in 1–3% of individuals infected with Human T-lymphotropic virus …

Human T-cell lymphotropic virus Type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a chronic progressive inflammatory neurological disease. It is …

Opinion statement Human T-lymphotrophic virus 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a disabling myelopathy, but clinical trials of specific drugs …

Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …

Human T-cell leukemia virus type 1 (HTLV-1) is the ethiologic agent of the neurological
disorder HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although …

Human T-lymphotropic virus type 1 (HTLV-1) is associated with adult T cell
leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis …

Human T‐lymphotropic virus type I (HTLV‐I)–associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is an immune‐mediated inflammatory disorder of the central …

Background: Human T cell lymphotropic virus type 1 (HTLV-1) is the agent of HTLV-1
associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of …

Human T‐lymphotropic virus type‐1 (HTLV‐1) was the first discovered human oncogenic
retrovirus, the etiological agent of two serious diseases have been identified as adult T‐cell …